Dermatology Practice Mergers, Acquisitions, Divestitures and Affiliations
Conducting Due Diligence, Meeting Regulatory Compliance Requirements, Overcoming Integration Challenges
Recording of a 90-minute CLE webinar with Q&A
This CLE course will provide guidance to counsel representing dermatology practices and investors when evaluating the various transaction structures for buying or selling a practice, conducting due diligence, and meeting regulatory compliance requirements. The panel will also offer best practices for executing dermatology practice deal transactions.
Outline
- Market conditions and trends
- Dermatology practice transaction structures
- Due diligence issues
- Corporate practice of medicine and fee splitting
- Noncompete enforceability
- Licenses
- Ancillary Services
- Regulatory compliance challenges
- HIPAA and patient records
- Stark / Anti-Kickback matters
- Integration challenges
- How buyers value dermatology practices
- Best practices
- How practices can enhance their value in preparation for sale or investment
Benefits
The panel will review these and other key issues:
- What are the regulatory compliance requirements and key diligence considerations in dermatology practice transactions?
- What impacts the fair market value of a dermatology practice?
- What best practices should counsel employ when assessing which structure should be used in a dermatology practice transaction?
Faculty
Richard S. Cooper
Member
McDonald Hopkins
Mr. Cooper is the manager of the firm’s National Healthcare Practice Group and is co-chair of its Healthcare... | Read More
Mr. Cooper is the manager of the firm’s National Healthcare Practice Group and is co-chair of its Healthcare Restructuring Practice Group. He focuses his national practice in healthcare law, representing clients in transactional, restructuring, corporate, compliance, regulatory, licensure, reimbursement, contractual, strategic planning, and venture matters. He represents a wide array of practice groups, including private practice and academic physician groups, hospitals and health systems, physician networks, laboratories, healthcare associations and societies, hospitalists and hospitalist companies, multi-specialty clinics, medical staffs, imaging centers, surgery centers, outpatient medical facilities, and home health providers.
CloseBradley V. Martorana
Counsel
Snell & Wilmer
Mr. Martorana has extensive experience advising businesses, tax exempt organizations, entrepreneurs and investors in... | Read More
Mr. Martorana has extensive experience advising businesses, tax exempt organizations, entrepreneurs and investors in structuring, negotiating and documenting a broad range of business transactions, including mergers and acquisitions, healthcare matters and corporate issues. He is also a certified public accountant with experience at one of the "big four" accounting firms. He is serving on the Task Force of the Mergers and Acquisitions Committee of the American Bar Association that is updating the ABA Model Stock Purchase Agreement. He is a frequent lecturer on mergers and acquisitions, corporate and healthcare matters.
CloseWilliam C. Bundy
Managing Director
Bundy Group
Mr. Bundy is an investment banker who has been involved with or overseen the closure of over 150 transactions across a... | Read More
Mr. Bundy is an investment banker who has been involved with or overseen the closure of over 150 transactions across a wide range of industries. He has worked substantially with dermatology groups. He is a frequent speaker and writer on the subjects of mergers and acquisitions and capital raises. He previously served on the Board of Directors of the M & A Source, an organization devoted to professional development for the investment banking field.
Close